{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:35Z","timestamp":1793413475224,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["PR-R17-0916-22001"],"award-info":[{"award-number":["PR-R17-0916-22001"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vaccine.2022.10.005","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:12:27Z","timestamp":1666224747000},"page":"7050-7056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England"],"prefix":"10.1016","volume":"40","author":[{"given":"Shari","family":"Sapuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Hallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.vaccine.2022.10.005_b0005","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.38.20587","article-title":"Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review","volume":"18","author":"Amirthalingam","year":"2013","journal-title":"Euro Surveill"},{"issue":"suppl 4","key":"10.1016\/j.vaccine.2022.10.005_b0010","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1093\/cid\/ciw559","article-title":"Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction","volume":"63","author":"Amirthalingam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.10.005_b0015","unstructured":"WHO. Weekly epidemiological record. 23 May 2014, vol. 89, 21. p. 221\u2013236."},{"key":"10.1016\/j.vaccine.2022.10.005_b0020","unstructured":"Public Health England. Health Protection Report 13(41), 20 December 2019."},{"issue":"11","key":"10.1016\/j.vaccine.2022.10.005_b0025","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/cid\/civ695","article-title":"Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator","volume":"61","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"9953","key":"10.1016\/j.vaccine.2022.10.005_b0030","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.vaccine.2022.10.005_b0035","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.vaccine.2022.10.005_b0040","first-page":"1257","article-title":"Immune responses in infants whose mothers received Tdap vaccine during pregnancy","volume":"32","author":"Hardy-Fairbanks","year":"2013","journal-title":"PIDJ"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.005_b0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2015.10.100","article-title":"Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.005_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vaccine.2015.10.098","article-title":"Pertussis vaccination during pregnancy in Vietnam: results of a randomized controlled trial Pertussis vaccination during pregnancy","volume":"34","author":"Hoang","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.10.005_b0055","doi-asserted-by":"crossref","unstructured":"Halperin SA, Langley JM, Ye L, et al. A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response. Clin Infect Dis. 2018;67(7):1063\u201371. doi:10.1093\/cid\/ciy244.","DOI":"10.1093\/cid\/ciy244"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.005_b0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-021-02005-5","article-title":"A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants","volume":"19","author":"Jones","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2022.10.005_b0065","unstructured":"Public Health England. Immunisation against infectious disease. Available from: https:\/\/www.gov.uk\/government\/collections\/immunisation-against-infectious-disease-the-green-book#the-green-book. Published 11 September 2013. Accessed July 23, 2020."},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.005_b0070","doi-asserted-by":"crossref","first-page":"e20153854","DOI":"10.1542\/peds.2015-3854","article-title":"Pertussis antibody concentrations in infants born prematurely to mothers vaccinated in pregnancy","volume":"138","author":"Kent","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.10.005_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.689394","article-title":"The effect of tetanus-diphtheria-acellular-pertussis immunization during pregnancy on infant antibody responses: individual-participant data meta-analysis","volume":"12","author":"Abu-Raya","year":"2021","journal-title":"Front Immunol"},{"issue":"44","key":"10.1016\/j.vaccine.2022.10.005_b0080","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1016\/j.vaccine.2021.09.022","article-title":"Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: individual-participant data meta-analysis","volume":"39","author":"Abu-Raya","year":"2021","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2022.10.005_b0085","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1016\/j.vaccine.2016.04.066","article-title":"Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.005_b0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/cid\/ciz778","article-title":"Quantity and quality of antibodies after acellular versus whole-cell pertussis vaccines in infants born to mothers who received tetanus, diphtheria, and acellular pertussis vaccine during pregnancy: a randomized trial","volume":"71","author":"Wanlapakorn","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22012439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22012439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:19:33Z","timestamp":1759403973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22012439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":18,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0264410X22012439"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}